Delivery Order SPE2DB20D3101-SPE2DB25FRJA4

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,842.36 firm fixed-price delivery order is for the supply of 4566413715 - Triamterene 50 mg Capsules, 100s, with a period of performance through November 14, 2024. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.30 firm fixed price delivery order contract is for the supply of Triamterene-HCTZ 37.5-25 mg capsules to support military healthcare programs. The contract has an ultimate completion date of August 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,756.59 firm fixed-price delivery order is for the supply of 4566748373 TRIAMTERENE 50 MG CAPSULE 100S, with a completion date of December 18, 2024. The contract is not designated with any set-aside requirements, indicating open competition. In addition to this specific delivery order, AmerisourceBergen holds a...
This federal contract award, valued at $13,670.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, covers the supply of TRIAMTERENE 50 MG CAPSULE 100S to support military healthcare programs. The contract is for a firm fixed-price delivery and...
This federal contract award, valued at $1,951.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIAMTERENE 100 MG CAPSULE 100S, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,540.52, is for the delivery of TRIAMTERENE 50 MG CAPSULE 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 11, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award to Amerisourcebergen Drug Corporation is a $4,903.30 Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The contract is for the supply of Triamterene 50 mg capsules, a pharmaceutical product, to support federal healthcare programs and services. The contract has a firm fixed price and an ultimate completion date of September 12, 2024. This award is part of Amerisourcebergen's extensive federal contracting...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Triamterene 50 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $1,664.92 and does not have a set-aside designation, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
This federal contract award, valued at $2,135.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product, with a period of performance through December 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,003.27, is a delivery order with a firm fixed price pricing type. It is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product, with a completion date of June 10, 2024. The contract does not have a set-aside designation, indicating open competition....
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRJA4
    Delivery Order

This federal contract award, SPE2DB20D3101|SPE2DB25FRJA4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,542.42 firm fixed-price delivery order is for the supply of 4,568,075,869 units of Triamterene 50 mg capsules. The contract has an ultimate completion date of April 30, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/29/25, 10:00 AM